Drug Database
Back to search

Finland· FI-REL-REL50754

Suvaxyn Circo

A porcine circovirus vaccine product containing porcine circovirus, type 2 orf2 protein, registered in Finland by Zoetis Belgium. The same ATC class is registered in 2 of our 19 countries.

ATC QI09AA07

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSuvaxyn CircoATCQI09AA07REGISTER NO.FI-REL-REL50754PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about porcine circovirus, type 2 orf2 proteinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Porcine circovirus, type 2 orf2 protein is registered in 2 of 19 countries.

Countries holding a registration under ATC QI09AA07 (porcine circovirus vaccine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose
Search porcine circovirus, type 2 orf2 protein products by name

Porcine circovirus, type 2 orf2 protein · ATC QI09AA07

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Porcine circovirus, type 2 ORF2 protein
Manufacturer
Zoetis Belgium
Country
Finland (FI)
ATC code
QI09AA07
ATC class
Porcine circovirus vaccine
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QI09AA07

Porcine circovirus vaccine, as other registers publish it.

All porcine circovirus, type 2 orf2 protein products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4f119aa-d517-4b97-a6f9-429eae49f618
GET /v1/drugs/b4f119aa-d517-4b97-a6f9-429eae49f618?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, emulsio",
  "route": "Lihakseen",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Porcine circovirus vaccine",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/17/223/001-006",
  "fimea_rel_id": "REL50754",
  "authorised_at": "2018-02-07"
}
API referenceMCP serverPlans

See everything about porcine circovirus, type 2 orf2 protein.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console